People with type 2 diabetes mellitus (T2DM) are at increased risk of mild cognitive
impairment and dementia. Systemic inflammation has been proposed as a common risk …

Globally, Alzheimer's disease (AD) is the most widespread chronic neurodegenerative
disorder, leading to cognitive impairment, such as aphasia and agnosia, as well as mental …

Longitudinal monitoring of patients suggests a causal link between chronic periodontitis and
the development of Alzheimer's disease (AD). However, the explanation of how periodontitis …

Metabolic syndrome (MS) is a set of cardio-metabolic risk factors that includes central
obesity, hyperglycemia, hypertension, and dyslipidemias. The syndrome affects 25% of …

Nowadays, Alzheimer's disease (AD) is a severe sociological and clinical problem. Since it
was first described, there has been a constant increase in its incidence and, for now, there …

Alzheimer's disease (AD) remains a medical and social challenge worldwide. Magnesium
(Mg) is one of the most frequently evaluated essential minerals with diverse biological …

Over the last century, there has been a gradual but sustained increase in life expectancy
globally. A consequence of increased life expectancy is an associated rise in the prevalence …

Alzheimer's disease (AD) represents a significant public health concern in modern society.
Metabolic syndrome (MetS), which includes diabetes mellitus (DM) and obesity, represents …

Increased amyloid beta (Aβ) levels and mitochondrial dysfunction (MD) in the human brain
characterize Alzheimer disease (AD). Folic acid, magnesium and vitamin B6 are essential …

This study aimed to quantitatively estimate the correlation between systemic inflammation
with cognitive function, as well as glycemic and lipid profiles in patients with type 2 diabetes …